BUSINESS Alembic Pharmaceuticals receives USFDA approval for Levothyroxine Sodium Tablets May 22, 2026
Alembic Pharmaceuticals secures USFDA approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3% Dec 11, 2025
Alembic Pharma shares rally sharply over 6% as Q2 net profit jumps 21% YoY to Rs 185 crore, revenue up 16% Nov 4, 2025
Alembic Pharma acquires UK-based Utility Therapeutics for $12 million to expand US presence Jul 3, 2025
Alembic Pharma share jump 11% after company gets US FDA approval for Doxorubicin Hydrochloride Injection Jun 30, 2025